D2 Dopamine Receptors Modulate Gα-Subunit Coupling of the CB1 Cannabinoid Receptor
- 1 March 2004
- journal article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 308 (3) , 880-886
- https://doi.org/10.1124/jpet.103.057620
Abstract
CB1 cannabinoid (CB1) and D2 dopamine (D2) receptors are known to couple to the G protein Gαi/o. It has been reported that concurrent activation of D2 receptors and CB1 receptors, in primary striatal neuronal culture, promotes functional CB1 receptor coupling to Gαs resulting in elevations in intracellular cyclic AMP levels. We now report that in the absence of D2 receptors, acute activation of CB1 receptors inhibits cyclic AMP accumulation, whereas the presence of D2 receptors promotes CB1-stimulated cAMP accumulation, presumably through Gαs. This Gαs subunit switching was not prevented by pertussis toxin treatment and occurred in the presence and absence of D2 receptor activation. Thus, coexpression of the D2 receptor with the CB1 receptor was sufficient to switch the coupling of the CB1 receptors from Gαi/o to Gαs. Persistent activation of D2 receptors resulted in heterologous sensitization of adenylate cyclase to subsequent stimulation by forskolin, whereas the persistent activation of CB1 receptors did not. Additional studies in human embryonic kidney cells cotransfected with D2 and CB1 receptors revealed that persistent activation (18 h) of D2 receptors induced a switch of CB1 receptor coupling from Gαs to Gαi/o. This D2 receptor-induced effect allowed for CB1 receptor-mediated inhibition of cyclic AMP accumulation. The present studies suggest D2 receptors may have a significant modulatory role in determining the G protein coupling specificity of CB1 receptors.Keywords
This publication has 27 references indexed in Scilit:
- Alterations in Detergent Solubility of Heterotrimeric G Proteins after Chronic Activation of Gi/o-Coupled Receptors: Changes in Detergent Solubility Are in Correlation with Onset of Adenylyl Cyclase SuperactivationMolecular Pharmacology, 2000
- Dopamine activation of endogenous cannabinoid signaling in dorsal striatumNature Neuroscience, 1999
- Enhanced Stimulatory Adenylyl Cyclase Signaling during Opioid Dependence Is Associated with a Reduction in Palmitoylated GsαMolecular Pharmacology, 1997
- Concurrent Stimulation of Cannabinoid CB1 and Dopamine D2 Receptors Augments cAMP Accumulation in Striatal Neurons: Evidence for a GsLinkage to the CB1 ReceptorJournal of Neuroscience, 1997
- Paradoxical action of the cannabinoid WIN 55,212‐2 in stimulated and basal cyclic AMP accumulation in rat globus pallidus slicesBritish Journal of Pharmacology, 1997
- Cannabinoid ligand-receptor signaling in the mouse uterus.Proceedings of the National Academy of Sciences, 1995
- Pharmacology of Cannabinoid ReceptorsAnnual Review of Pharmacology and Toxicology, 1995
- Dopaminergic Regulation of Cannabinoid Receptor mRNA Levels in the Rat Caudate‐Plitamen: An In Situ Hybridization StudyJournal of Neurochemistry, 1993
- Increased forskolin binding in the left parahippocampal gyrus and CA1 region in post mortem schizophrenic brain determined by quantitative autoradiographyNeuroscience Letters, 1990
- Cannabinoid receptor localization in brain.Proceedings of the National Academy of Sciences, 1990